SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
1-Year Return
40.04%
This Quarter Return
-3.86%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$103M
AUM Growth
-$21.1M
(-17%)
Cap. Flow
+$6.61M
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
58.07%
Holding
75
New
23
Increased
18
Reduced
24
Closed
9
Top Buys
| 1 |
ANI Pharmaceuticals
ANIP
|
$7.85M |
| 2 |
OPTN
OptiNose
OPTN
|
$1.83M |
| 3 |
Surrozen
SRZN
|
$1.73M |
| 4 |
Edesa Biotech
EDSA
|
$1.68M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$1.43M |
Top Sells
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$2.87M |
| 2 |
Galapagos
GLPG
|
$2.66M |
| 3 |
Evolus
EOLS
|
$1.56M |
| 4 |
Verastem
VSTM
|
$1.55M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$1.23M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Acadia Pharmaceuticals
ACAD
$4.26B
| $186K | 0.18% |
93,393
-126,607
| -58% | -$252K |
|
52
Corbus Pharmaceuticals
CRBP
$121M
| $186K | 0.18% |
+35,000
| New | +$186K |
|
53
Vanda Pharmaceuticals
VNDA
$272M
| $161K | 0.16% |
35,148
+10,148
| +41% | +$46.6K |
|
54
PolyPid
PYPD
$54.8M
| $149K | 0.15% |
54,975
-48,693
| -47% | -$132K |
|
|
AMRN
55
Amarin Corp
AMRN
$317M
| $105K | 0.1% |
32,581
+26,868
| +470% | +$86.6K |
|
56
Elanco Animal Health
ELAN
$9.16B
| $105K | 0.1% |
+10,000
| New | +$105K |
|
57
Zentalis Pharmaceuticals
ZNTL
$126M
| $95.4K | 0.09% |
+60,000
| New | +$95.4K |
|
|
WHWK
58
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
| $83.1K | 0.08% |
+46,698
| New | +$83.1K |
|
59
Savara
SVRA
$643M
| $80.5K | 0.08% |
+29,079
| New | +$80.5K |
|
60
Iovance Biotherapeutics
IOVA
$901M
| $66.6K | 0.06% |
+20,000
| New | +$66.6K |
|
|
THTX
61
Theratechnologies
THTX
$150M
| $36.2K | 0.04% |
+25,825
| New | +$36.2K |
|
62
ADMA Biologics
ADMA
$4.03B
| $24.3K | 0.02% |
810,000
-431,032
| -35% | -$12.9K |
|
63
Emergent Biosolutions
EBS
$404M
| $24.3K | 0.02% |
+5,000
| New | +$24.3K |
|
64
Nkarta
NKTX
$161M
| $18.4K | 0.02% |
+10,000
| New | +$18.4K |
|
65
Aprea Therapeutics
APRE
$9.03M
| $14.4K | 0.01% |
102,242
-46,979
| -31% | -$6.62K |
|
66
Esperion Therapeutics
ESPR
$540M
| $14.4K | 0.01% |
+10,000
| New | +$14.4K |
|
|
ABVX
67
Abivax
ABVX
$6.65B
| – | – |
-15,000
| Closed | -$110K |
|
|
ALLR
68
Allarity Therapeutics
ALLR
$28.8M
| – | – |
-67,289
| Closed | -$78.7K |
|
69
AN2 Therapeutics
ANTX
$34.4M
| – | – |
-196,732
| Closed | -$271K |
|
|
ELEV
70
DELISTED
Elevation Oncology
ELEV
| – | – |
-200,000
| Closed | -$113K |
|
|
71
Ironwood Pharmaceuticals
IRWD
$188M
| – | – |
-648,785
| Closed | -$2.87M |
|
|
72
Jazz Pharmaceuticals
JAZZ
$7.86B
| – | – |
-10,000
| Closed | -$1.23M |
|
|
TSVT
73
DELISTED
2seventy bio
TSVT
| – | – |
-300,000
| Closed | -$882K |
|
|
RVNC
74
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-23,264
| Closed | -$70.7K |
|